載入...
Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice
4-Aminopyridine (4-AP), an FDA-approved drug for the symptomatic treatment of multiple sclerosis, is used to improve neuromuscular function in patients with diverse demyelinating disorders. We recently demonstrated that local, transdermal or injectable forms of 4-AP improve myelination, nerve conduc...
Na minha lista:
| 發表在: | Neural Regen Res |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer - Medknow
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7716044/ https://ncbi.nlm.nih.gov/pubmed/32394968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.280319 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|